Live imaging of amyotrophic lateral sclerosis pathogenesis: Disease onset is characterized by marked induction of GFAP in Schwann cells

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Glia

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/glia.20836PMID 19115383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Live Imaging of Neuroinflammation Reveals Sex and Estrogen Effects on Astrocyte Response to Ischemic Injury

  2008cited by this paper
• Adult glial precursor proliferation in mutant SOD1G93A mice

  2008cited by this paper
• Real-time imaging of astrocyte response to quantum dots: in vivo screening model system for biocompatibility of nanoparticles.

  2007cited by this paper
• NG2 cells generate both oligodendrocytes and gray matter astrocytes

  2007cited by this paper
• Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model

  2007cited by this paper
• Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons

  2007cited by this paper
• Complete Dissociation of Motor Neuron Death from Motor Dysfunction by Bax Deletion in a Mouse Model of ALS

  2006cited by this paper
• Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS.

  2006cited by this paper
• Absence of Tumor Necrosis Factor-α Does Not Affect Motor Neuron Disease Caused by Superoxide Dismutase 1 Mutations

  2006cited by this paper
• Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage

  2006influential reference
• Review ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors

  2006cited by this paper
• Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis

  2006cited by this paper
• ALS: a disease of motor neurons and their nonneuronal neighbors.

  2006cited by this paper
• Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF

  2006influential reference
• Fibroblast Growth Factor-1 Induces Heme Oxygenase-1 via Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) in Spinal Cord Astrocytes

  2005cited by this paper
• Fibroblast Growth Factor-1 Induces Heme Oxygenase-1 via Nuclear Factor Erythroid 2-related Factor 2 (Nrf2) in Spinal Cord Astrocytes CONSEQUENCES FOR MOTOR NEURON SURVIVAL*

  2005cited by this paper
• A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis

  2005cited by this paper
• Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

  2004influential reference
• Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease

  2004cited by this paper
• Non-invasive imaging of GFAP expression after neuronal damage in mice.

  2004cited by this paper
• Efficient three‐drug cocktail for disease induced by mutant superoxide dismutase

  2003cited by this paper
• Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice

  2003cited by this paper
• In vivo proliferation, migration and phenotypic changes of Schwann cells in the presence of myelinated fibers.

  2002influential reference
• Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury

  2002cited by this paper
• Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)

  2002cited by this paper
• Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration.

  2002cited by this paper
• Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis.

  2002cited by this paper
• Whole-animal cellular and molecular imaging to accelerate drug development.

  2002influential reference
• Degeneration of corticospinal and bulbospinal systems in the superoxide dismutase 1(G93A G1H) transgenic mouse model of familial amyotrophic lateral sclerosis.

  2002cited by this paper
• From charcot to lou gehrig: deciphering selective motor neuron death in als

  2001influential reference
• Early and Selective Loss of Neuromuscular Synapse Subtypes with Low Sprouting Competence in Motoneuron Diseases

  2000cited by this paper
• A quantitative study of the progress of myelination in the rat central nervous system, using the immunohistochemical method for proteolipid protein.

  1998cited by this paper
• Modulation of synaptic efficacy and synaptic depression by glial cells at the frog neuromuscular junction.

  1998cited by this paper
• Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.

  1998influential reference
• ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

  1997influential reference
• Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.

  1996cited by this paper
• An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

  1995influential reference
• Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

  1994cited by this paper
• Synaptic regulation of glial protein expression in vivo.

  1994influential reference
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

  1993cited by this paper
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

  1993cited by this paper
• Atomic structure and chemistry of human serum albumin

  1993cited by this paper
• Reactions of the Immune System in Chronic Degenerative Neurological Diseases

  1991cited by this paper
• Three markers of adult non-myelin-forming Schwann cells, 217c(Ran-1), A5E3 and GFAP: development and regulation by neuron-Schwann cell interactions.

  1990cited by this paper
• Quantitative analysis of myelin protein gene expression during development in the rat sciatic nerve.

  1990cited by this paper
• THE GEOMETRY OF PERIPHERAL MYELIN SHEATHS DURING THEIR FORMATION AND GROWTH IN RAT SCIATIC NERVES

  1971cited by this paper
• The quantitative measurement of motor inco‐ordination in naive mice using an accelerating rotarod

  1968cited by this paper
• The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod.

  1968cited by this paper

• Astrocytic activation of EMMPRIN contributes to their pathological phenotype in ALS

  2025cites this paper
• Pathologic and Therapeutic Schwann Cells

  2025cites this paper
• Schwann cells as a therapeutic target for Amyotrophic Lateral Sclerosis: A TDP-43 Focussed Review.

  2025cites this paper
• Bridging neuro-biomarkers and MR imaging: The synergistic role of glial fibrillary acidic protein in early CNS disease diagnosis

  2025cites this paper
• Blood diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis

  2024cites this paper
• Neuromuscular junction dysfunction in Lafora disease

  2024cites this paper
• Đánh giá hiệu quả điều trị của tế bào CAR-T trên chuột mang tế bào u lympho dòng B thể lan tỏa

  2023cites this paper
• A Novel Therapy for ALS: Allogeneic Schwann Cell Extracellular Vesicles

  2023cites this paper
• In vitro modelling of human proprioceptive sensory neurons in the neuromuscular system

  2022cites this paper
• Bioluminescence and Optical Imaging: Principles and Applications

  2021cites this paper
• Evolving Techniques in Peripheral Nerve Regeneration.

  2021cites this paper
• Anti-inflammatory Effects of a Novel Herbal Extract in the Muscle and Spinal Cord of an Amyotrophic Lateral Sclerosis Animal Model

  2021cites this paper
• Diaphragm Neuromuscular Transmission Failure in a Mouse Model of an Early-Onset Neuromotor Disorder.

  2020cites this paper
• Neurodegenerative Diseases – Is Metabolic Deficiency the Root Cause?

  2020cites this paper
• 11C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis

  2020cites this paper
• Detection of amyloid aggregation in living systems

  2020cites this paper
• Bioluminescence imaging in mice with synthetic luciferin analogues.

  2020influential citation
• Wnt Signaling Alterations in the Human Spinal Cord of Amyotrophic Lateral Sclerosis Cases: Spotlight on Fz2 and Wnt5a

  2019cites this paper
• Gender-Specific Beneficial Effects of Docosahexaenoic Acid Dietary Supplementation in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice

  2019cites this paper
• In vivo Bioluminescence Imaging Used to Monitor Disease Activity and Therapeutic Response in a Mouse Model of Tauopathy

  2019cites this paper
• Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL‐34, and SCF in amyotrophic lateral sclerosis

  2019cites this paper
• Toward in vivo determination of peripheral nervous system immune activity in amyotrophic lateral sclerosis

  2019influential citation
• Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS

  2018cites this paper
• Astrocytes expressing ALS‐linked mutant FUS induce motor neuron death through release of tumor necrosis factor‐alpha

  2018cites this paper
• Investigating Inflammatory Pathways as Therapeutic Targets and Biomarkers using Functional Imaging and Pharmacological Interventions in Epilepsy Models.

  2018cites this paper
• Counteracting roles of MHCI and CD8+ T cells in the peripheral and central nervous system of ALS SOD1G93A mice

  2018cites this paper
• Clinical relevance of terminal Schwann cells: An overlooked component of the neuromuscular junction

  2018cites this paper
• Mouse models of neurodegenerative disease: preclinical imaging and neurovascular component

  2017cites this paper
• Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils.

  2017cites this paper
• Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis

  2017cites this paper
• Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis

  2016cites this paper
• IL-10 Controls Early Microglial Phenotypes and Disease Onset in ALS Caused by Misfolded Superoxide Dismutase 1

  2016cites this paper
• Bioluminescence imaging of hepatic nutrient fluxes

  2016cites this paper
• New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction

  2016influential citation
• Immune response in peripheral axons delays disease progression in SOD1G93A mice

  2016cites this paper
• Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).

  2016influential citation
• Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

  2016cites this paper
• Bioluminescence imaging in live cells and animals

  2016cites this paper
• Histological–MRI correlation in the primary motor cortex of patients with amyotrophic lateral sclerosis

  2015cites this paper
• Gene therapy and peripheral nerve repair: a perspective

  2015cites this paper
• Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression

  2015cites this paper
• Patient-derived olfactory mucosa for study of the non-neuronal contribution to amyotrophic lateral sclerosis pathology

  2015cites this paper
• Early and Persistent Abnormal Decoding by Glial Cells at the Neuromuscular Junction in an ALS Model

  2015cites this paper
• Remote-controlled eradication of astrogliosis in spinal cord injury via electromagnetically-induced dexamethasone release from "smart" nanowires.

  2015cites this paper
• Development of new therapeutic approaches in mouse models of Amyotrophic Lateral Sclerosis

  2015cites this paper
• Short report Open Access

  2015cites this paper
• Dysregulated expression of death, stress and mitochondrion related genes in the sciatic nerve of presymptomatic SOD1G93A mouse model of Amyotrophic Lateral Sclerosis

  2015influential citation
• Gene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration

  2015cites this paper
• High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression

  2015cites this paper
• Amyotrophic Lateral Sclerosis: A Glial Perspective

  2014cites this paper
• Glial cells in amyotrophic lateral sclerosis.

  2014cites this paper
• Early-Stage Treatment with Withaferin A Reduces Levels of Misfolded Superoxide Dismutase 1 and Extends Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis

  2014cites this paper
• Amyotrophic Lateral Sclerosis: A Focus on Disease Progression

  2014cites this paper
• ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease

  2014cites this paper
• Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1G93A Amyotrophic Lateral Sclerosis mouse model

  2014cites this paper
• Defining peripheral nervous system dysfunction in the SOD-1G93A transgenic rat model of amyotrophic lateral sclerosis.

  2014cites this paper
• Microglia centered pathogenesis in ALS: insights in cell interconnectivity

  2014cites this paper
• The Emerging Use of In Vivo Optical Imaging in the Study of Neurodegenerative Diseases

  2014influential citation
• Inflammation and neurovascular changes in amyotrophic lateral sclerosis.

  2013cites this paper
• Therapeutic neuroprotective agents for amyotrophic lateral sclerosis

  2013cites this paper
• Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.

  2013cites this paper
• Proteomic Analysis Reveals Differentially Regulated Protein Acetylation in Human Amyotrophic Lateral Sclerosis Spinal Cord

  2013cites this paper
• Biaryl Amides and Hydrazones as Therapeutics for Prion Disease in Transgenic Mice

  2013cites this paper
• Making the Brain Glow: In Vivo Bioluminescence Imaging to Study Neurodegeneration

  2013cites this paper
• Neuron–Astrocyte Interactions in Neuroinflammation

  2013cites this paper
• Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis

  2013cites this paper
• GFAP expression as an indicator of disease severity in mouse models of Alexander disease

  2013influential citation
• Real-time imaging after cerebral ischemia: model systems for visualization of inflammation and neuronal repair.

  2012cites this paper
• The construction of transgenic and gene knockout/knockin mouse models of human disease

  2012cites this paper
• Selective knockdown of mutant SOD1 in Schwann cells ameliorates disease in G85R mutant SOD1 transgenic mice.

  2012cites this paper
• Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons.

  2012cites this paper
• Abnormal Regenerative Responses and Impaired Axonal Outgrowth after Nerve Crush in TDP-43 Transgenic Mouse Models of Amyotrophic Lateral Sclerosis

  2012cites this paper
• The Astrocytic Contribution in ALS: Inflammation and Excitotoxicity

  2012cites this paper
• Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice.

  2011cites this paper
• Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.

  2011cites this paper
• Relationship between neuropathology and disease progression in the SOD1(G93A) ALS mouse.

  2011cites this paper
• Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.

  2011cites this paper
• Bioluminescence imaging: progress and applications.

  2011cites this paper
• Astrocyte-neuron metabolic relationships: for better and for worse.

  2011cites this paper
• Bioluminescence imaging of Aβ deposition in bigenic mouse models of Alzheimer's disease

  2011influential citation
• GFAP in health and disease.

  2011cites this paper
• Model System for Live Imaging of Neuronal Responses to Injury and Repair

  2011cites this paper
• Systems Biology and the Discovery of Diagnostic Biomarkers

  2010cites this paper
• Unraveling the complexity of amyotrophic lateral sclerosis: recent advances from the transgenic mutant SOD1 mice.

  2010cites this paper
• Activation transcription factor-3 activation and the development of spinal cord degeneration in a rat model of amyotrophic lateral sclerosis.

  2010cites this paper
• Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis

  2010cites this paper
• Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.

  2010cites this paper
• In Vivo Bioluminescent Imaging (BLI): Noninvasive Visualization and Interrogation of Biological Processes in Living Animals

  2010cites this paper
• Acute glial activation by stab injuries does not lead to overt damage or motor neuron degeneration in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis.

  2010cites this paper
• Oxidative Stress Resistance in Drosophila melanogaster

  2010cites this paper
• Inflammation, plasticity and real-time imaging after cerebral ischemia

  2009cites this paper
• Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials

  2009cites this paper
• Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice

  2009cites this paper
• Measuring prions by bioluminescence imaging

  2009cites this paper
• Portal Semaphorin 3 A in injury and disease : its role at the neuromuscular junction

  year unknowncites this paper
• Cellular and Molecular Life Sciences the Multifaceted Role of Glial Cells in Amyotrophic Lateral Sclerosis

  year unknowncites this paper
• Title : Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse 1 model of ALS 2

  year unknowncites this paper